Chief Business Officer
Aris Theologis is responsible for all business aspects of Evozyne including its commercial development work, go-to-market strategy, finance, and long-term strategic direction. Previously, Aris worked in strategy and business development at Castlight Health. He previously co-founded and served as CEO of Avva Health and was an Amil-Harvard Fellow. He began his career on the commercial team at Crescendo Bioscience. Aris holds an MBA from Harvard Business School and a bachelor’s degree with honors in biochemistry and biophysics from Stanford University.